Skip to main content
Heidi Cuthbert CEO Grafa
Heidi Cuthbert

Heidi Cuthbert

GrafaCEO & Founder

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.

Articles by Heidi Cuthbert

Grafa

Merck gains FDA approval for Keytruda plus Trodelvy in first-line TNBC

Merck (NYSE:MRK) announced that the U.S. Food and Drug Administration approved KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph), each in combination with Trodelvy (sacituzumab govitecan-hziy), for the first-line treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer whose tumors express PD-L1 (CPS ≥10).

Read more: Merck gains FDA approval for Keytruda plus Trodelvy in first-line TNBC